OncoSec purchasing Inovio's selective electrochemical tumor ablation (SECTA) technology and with a non-exclusive, worldwide license to non-SECTA IP.

Inovio Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

OncoSec Medical Inc.

U.S. / Medical Devices and Diagnostics

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced